Twist Bioscience Corporation (TWST) vs Whitehawk Therapeutics, Inc. (WHWK)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| TWST | WHWK | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Size band | MID | SMALL |
| Listing | Nasdaq GS | Nasdaq CM |
| Country | United States | United States |
| Theme | life-science-tools | oncology |
| Price and returns | ||
| Last close | $145.25 | $3.14 |
| Return · 1 week | +3.92% | +4.32% |
| Return · 1 month | −19.13% | −16.49% |
| Return · 3 months | +64.03% | −14.67% |
| Return · year to date | +348.44% | +28.69% |
| Return · 1 year | +324.96% | +29.75% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −33.89% | −42.86% |
| 52-week high | $219.71 | $5.50 |
| 52-week low | $23.30 | $1.97 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $9.63B | $179.01M |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $302.09M | $847.17K |
| Employees | 979 | 32 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | — |
| Price to earnings · forward | n/a (negative forward earnings) | — |
| Price to sales | 20.38× | — |
| Price to book | 18.67× | — |
| Enterprise value to EBITDA | n/a (negative EBITDA) | — |
| Enterprise value to revenue | 19.14× | — |
| Earnings per share · trailing | -2.23 | — |
| Profitability | ||
| Gross margin | 51.97% | — |
| Operating margin | −30.65% | — |
| Profit margin | −31.66% | — |
| Return on equity | −29.59% | — |
| Return on assets | −13.09% | — |
| Growth | ||
| Revenue growth | +23.20% | — |
| Balance sheet and payout | ||
| Debt / equity (%) | 24.36 | — |
| Current ratio | 2.67 | — |
| Dividend yield | 0.00% | — |
| Trend and volatility | ||
| RSI · 14 | 38.20 | 39.48 |
| ADX · 14 | 25.91 | 17.14 |
| 50-day average | $147.91 | $4.29 |
| 200-day average | $83.26 | $3.72 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 11.43% | 6.11% |
The full TWST analysis
Everything this table leaves out for Twist Bioscience Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the TWST argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full TWST analysisThe full WHWK analysis
Everything this table leaves out for Whitehawk Therapeutics, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the WHWK argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full WHWK analysis